Future outperforming subsectors in pharma

Future outperforming subsectors in pharma

Oncology, immunology & neurology will outperform the overall pharmaceutical sector over the coming decade. Innovation will drive this out-performance. IQVIA estimates annual spending on oncology and immunology will reach US$ 273bn and US$ 175bn respectively, with over 100 new...

Continue reading →

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Will cooperation between Healthcare firms continue as a trend, increasing healthcare M&A?

Siemens Healthineers (SHL.DE) announced that it would acquire Varian Medical Systems (VAR) on the 2nd of August 2020 for USD 16.4bn. Siemens will purchase all of Varian's shares for $177.50/share in cash; a 24% premium. The deal will be financed...

Continue reading →

What can ants and bees teach us about containing disease

What can ants and bees teach us about containing disease

Nathalie Stroeymeyt, a senior lecturer in the School of Biological Sciences at the University of Bristol, drew parallels from the guides to social distancing during the Covid-19 pandemic and how ants behave in a recent research study. The research was...

Continue reading →

Competition lowers drug prices, FDA says

Competition lowers drug prices, FDA says

According to a report by the US Food and Drug Administration (FDA), increased generic drug entry will lead to price reductions in the market (see our table below) as well as huge savings opportunities for patients, or at least...

Continue reading →